These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36157542)

  • 41. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
    Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
    Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
    Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
    Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.
    Eggert E; Hillig RC; Koehr S; Stöckigt D; Weiske J; Barak N; Mowat J; Brumby T; Christ CD; Ter Laak A; Lang T; Fernandez-Montalvan AE; Badock V; Weinmann H; Hartung IV; Barsyte-Lovejoy D; Szewczyk M; Kennedy S; Li F; Vedadi M; Brown PJ; Santhakumar V; Arrowsmith CH; Stellfeld T; Stresemann C
    J Med Chem; 2016 May; 59(10):4578-600. PubMed ID: 27075367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.
    Su Z; Su H; Xu J; Wei G; Qu L; Ni T; Yang D; Zhu Y
    Aging (Albany NY); 2022 Dec; 15(1):70-91. PubMed ID: 36585926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation.
    Li L; Bao J; Wang H; Lei JH; Peng C; Zeng J; Hao W; Zhang X; Xu X; Yu C; Deng CX; Chen Q
    Theranostics; 2021; 11(4):1672-1689. PubMed ID: 33408774
    [No Abstract]   [Full Text] [Related]  

  • 47. Epigenetic targeting DNMT1 of pancreatic ductal adenocarcinoma using interstitial control release biodegrading polymer reduced tumor growth through hedgehog pathway inhibition.
    Huang MH; Chou YW; Li MH; Shih TE; Lin SZ; Chuang HM; Chiou TW; Su HL; Harn HJ
    Pharmacol Res; 2019 Jan; 139():50-61. PubMed ID: 30385365
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse.
    Urrutia G; Salmonson A; Toro-Zapata J; de Assuncao TM; Mathison A; Dusetti N; Iovanna J; Urrutia R; Lomberk G
    Mol Cancer Res; 2020 Mar; 18(3):448-462. PubMed ID: 31822519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ribosomal protein eL21 interacts with the protein lysine methyltransferase SMYD2 and regulates its steady state levels.
    Khan MIK; Charles RCM; Ramachandran R; Gupta S; Govindaraju G; Mishra R; Rajavelu A; Coumar MS; Chavali S; Dhayalan A
    Biochim Biophys Acta Mol Cell Res; 2021 Aug; 1868(9):119079. PubMed ID: 34147559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
    Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
    J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
    Roca MS; Moccia T; Iannelli F; Testa C; Vitagliano C; Minopoli M; Camerlingo R; De Riso G; De Cecio R; Bruzzese F; Conte M; Altucci L; Di Gennaro E; Avallone A; Leone A; Budillon A
    J Exp Clin Cancer Res; 2022 Mar; 41(1):83. PubMed ID: 35241126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS.
    Xie F; Li C; Zhang X; Peng W; Wen T
    Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The histone methyltransferase Smyd2 is a negative regulator of macrophage activation by suppressing interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α) production.
    Xu G; Liu G; Xiong S; Liu H; Chen X; Zheng B
    J Biol Chem; 2015 Feb; 290(9):5414-23. PubMed ID: 25583990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression.
    Kim SS; Xu S; Cui J; Poddar S; Le TM; Hayrapetyan H; Li L; Wu N; Moore AM; Zhou L; Yu AC; Dann AM; Elliott IA; Abt ER; Kim W; Dawson DW; Radu CG; Donahue TR
    Theranostics; 2020; 10(2):829-840. PubMed ID: 31903153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
    Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma.
    Xu R; Xu Q; Huang G; Yin X; Zhu J; Peng Y; Song J
    Biomed Res Int; 2019; 2019():9379864. PubMed ID: 31956659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
    Yu Y; Wang Z; Mo DH; Wang Z; Li G
    Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smyd2 conformational changes in response to p53 binding: role of the C-terminal domain.
    Chandramouli B; Melino G; Chillemi G
    Mol Oncol; 2019 Jun; 13(6):1450-1461. PubMed ID: 31069954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.